AFC Ajax N.V. (0DI7)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 7.680 |
|---|---|
| 52-week range | 7.620 – 9.500 |
| Return, 1 month / 3 months | −9.6% / −9.4% |
| Return, 1 year / 3 years | −16.9% / −26.6% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 19.9% |
| Worst drawdown (1 year) | -17.8% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AFC Ajax is a professional football club based in Amsterdam in the Netherlands. The club runs a men's first team that plays in Dutch domestic league and cup competitions and in European club tournaments, and it also develops young players through its youth academy. Its customers are football supporters who attend matches and follow the team, along with commercial partners and broadcasters. The club is organised as a public limited company, and its activities centre on the football operation and the stadium.
The shares are listed on the London Exchange in UK under the code 0DI7, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AFC Ajax N.V. (0DI7) trades on the London Exchange in UK. It last closed at EUR 7.680 on 23 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 2,482 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.9% and over the last three months it fell 9.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.1% | ||
| From 52-week high | -17.8% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.4% | ||
| 6-month return | -12.9% | ||
| 12-month return, skipping the last month | -8.0% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.8% | ||
| Liquidity | 5 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.0% |
|---|---|
| 1 month | −9.6% |
| 3 months | −9.4% |
| 6 months | −12.9% |
| 1 year | −16.9% |
| 3 years | −26.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 8.479 / 8.635 |
|---|---|
| Golden / death cross (60 days) | Death, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.177 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Nov 2023 | EUR 0.0900 |
| 19 Nov 2019 | EUR 0.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.